Effect of Interferon-Beta Treatment on the Proportion of Th17 Cells and Related Cytokines in Multiple Sclerosis: A Meta-Analysis

Journal of Interferon and Cytokine Research - United States
doi 10.1089/jir.2019.0065
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

Treatment Recommendations for Interferon-Beta in Multiple Sclerosis

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1999English

The Effect of Interferon-Beta on Oxidative Stress in Patients With Multiple Sclerosis

Annals of the College of Medicine, Mosul
2018English

Comparison of Peripheral Blood Th17 Cells and Associated Cytokines in Fingolimod-Receiving and Untreated Multiple Sclerosis Patients

Turkish Journal of Immunology
2019English

Multiple Sclerosis-Linked and Interferon-Beta-Regulated Gene Expression in Plasmacytoid Dendritic Cells

Journal of Neuroimmunology
AllergyImmunologyNeurology
2012English

Effect on Cognition of Estroprogestins Combined With Interferon Beta in Multiple Sclerosis: Analysis of Secondary Outcomes From a Randomised Controlled Trial

CNS Drugs
PsychiatryMental HealthNeurologyPharmacology
2016English

Oxidative Modification of Blood Serum Proteins in Multiple Sclerosis After Interferon Beta and Melatonin Treatment

Oxidative Medicine and Cellular Longevity
BiochemistryMedicineCell BiologyAging
2017English

Interferon Beta Treatment for Multiple Sclerosis Has a Graduated Effect on MRI Enhancing Lesions According to Their Size and Pathology

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1999English

Erythema Elevatum Et Diutinum, Multiple Sclerosis and Interferon Beta

Dermatology
Dermatology
2004English

Inhibition of Interferon-Beta Responses in Multiple Sclerosis Immune Cells Associated With High-Dose Statins

Archives of Neurology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy